Clinical Trial Update: Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

View source ↗

Summary

This clinical trial update describes a study examining whether corpus callosum atrophy can predict subsequent cognitive impairment in patients with multiple scl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Multiple Sclerosis

Snippet

Sponsor: Cantonal Hospital of St. Gallen | Conditions: Multiple Sclerosis, Cognitive Impairment | Status: UNKNOWN